Common questions about Lantus (FAQ)
Q: What is Lantus used for besides diabetes?
According to official regulatory documents, Lantus (insulin glargine) is indicated solely for helping to improve glycemic control (blood sugar levels) in adult and pediatric patients who have diabetes mellitus.
Q: Does Lantus interact with alcohol?
Official regulatory information documents that consuming alcohol while using Lantus is linked to an increased risk of severe hypoglycemia, which is critically low blood sugar. This is considered a pharmacodynamic interaction that affects the overall glucose-lowering effect.
Q: Can Lantus be taken with common pain relievers like Tylenol (acetaminophen)?
Regulatory documents state that certain drugs, such as high-dose salicylates (another type of pain reliever), may increase the glucose-lowering effect of insulin. While acetaminophen is not specifically listed in interaction tables, many over-the-counter products can affect blood glucose levels. Regulatory documents state that patients receiving insulin therapy should closely monitor blood glucose when initiating new medications.
Q: What kind of monitoring is needed when starting Lantus?
Regulatory documents emphasize that glucose monitoring is essential for all patients receiving insulin. Any changes to an insulin regimen, including strength, type, or dose, must be made cautiously under medical supervision and require close monitoring of blood glucose levels to reach appropriate glycemic control goals.
Q: Can I split my Lantus dose into two injections per day?
Official administration instructions mandate that Lantus should be administered once daily to achieve its intended sustained action profile. Regulatory documents do not provide instruction or recommendation for splitting the daily dose into two injections, as this may interfere with the drug's intended action over 24 hours.
Q: Is the way Lantus is stored important?
Yes. Regulatory documents specify strict storage conditions (e.g., refrigeration for unopened product, limited duration for in-use product, and protection from freezing or high heat). Improper storage, such as exposure to freezing or high heat, can compromise the stability and potency of the insulin as described in official documents.
Q: Can travel to different time zones affect my Lantus schedule?
The official instruction is to administer Lantus once daily at the same time each day. Regulatory documents indicate that the timing of the insulin dose may require adjustment if a patient's life-style changes or other circumstances arise. Dose or timing adjustments based on lifestyle changes, such as time zone travel, must be done under the direction of a healthcare professional.
Q: Is it normal to feel a stinging sensation when injecting Lantus?
Injection site reactions, such as pain, redness, and swelling, are listed as Common side effects in official regulatory documents. While the feeling of 'stinging' is not explicitly listed, injection site pain is a documented event that is often transient (temporary).
Q: Is Lantus safe for use during pregnancy?
Official documents state that the use of Lantus during pregnancy is recommended only if the potential benefit justifies the potential risk. Published studies have not reported a clear association with adverse outcomes. Poorly controlled diabetes poses known risks during pregnancy, which underscores the importance of close monitoring.
Q: Can stress or illness change how effective Lantus is?
Regulatory information indicates that factors such as stress or intercurrent illness (sickness) can alter blood glucose levels in the body. These situations may alter blood glucose levels, which may require adjustment to the administered insulin dose or treatment regimen.
Q: Can I switch from my current long-acting insulin to Lantus?
Regulatory documents describe the process for switching between different basal (long-acting) insulin regimens. It is noted that a change of the dose of the basal insulin is often required and must be done under close metabolic monitoring by a healthcare provider, as required by regulatory guidance.
Q: Why is Lantus sometimes taken at night?
Official documents state that Lantus can be taken once daily at any time of the day. Research supporting its use often focuses on monitoring nocturnal hypoglycemia (low blood sugar during sleep). Taking it at night may be one timing strategy used to help minimize the risk of low blood sugar events while sleeping.
Q: What are the components (ingredients) of Lantus besides the active drug?
In addition to the active ingredient, Insulin Glargine, regulatory documents list several excipients (inactive ingredients). These components often include zinc chloride, the preservative m-cresol, glycerol, and water for injections, with hydrochloric acid and sodium hydroxide used to ensure the solution is at the correct pH.
Q: Is there a risk of long-term side effects from Lantus use?
Official safety documents list potential effects associated with long-term exposure, such as Lipodystrophy (changes in fat tissue at the injection site). Also, long-term studies, such as major cardiovascular outcome trials, were conducted to monitor high-level safety endpoints over several years, finding the incidence of events comparable to standard care.
Q: How is the safety of Lantus monitored by regulatory agencies?
Safety is continuously monitored through the required reporting of adverse reactions by frequency (e.g., Very Common, Common) and the mandated post-marketing surveillance of serious safety considerations. This process ensures regulatory bodies track the potential for events such as severe hypoglycemia and anaphylaxis after the drug is on the market.
Q: Can Lantus interact with medications for thyroid issues?
Regulatory documents list Thyroid hormone products as drugs that may decrease the blood glucose-lowering effect of insulin. This means that taking both types of medication may potentially lead to a risk of high blood sugar. Close monitoring and possible dose adjustment are noted in regulatory information as potentially necessary.
Q: Why are people with specific eye conditions sometimes advised about Lantus?
Official documents note that a rapid, intense improvement in glycemic control, such as when beginning insulin, may be associated with a temporary worsening of diabetic retinopathy. Also, severe hypoglycemic episodes may rarely result in transient vision loss. This information is included in regulatory documents to ensure careful monitoring during initiation of treatment.
Q: Can I exercise right after injecting Lantus?
Regulatory information indicates that the rate of absorption and consequently the effect of insulin may be affected by physical activity and the local blood supply to the injection site. Increased blood flow from exercise can potentially increase insulin absorption, which may increase the risk of hypoglycemia.
Q: Is there a restriction on driving while using Lantus?
Regulatory documents warn that a patient's ability to concentrate and react may be impaired due to hypoglycemia (low blood sugar). This may create a safety risk in situations like driving a vehicle or operating machinery. Frequent glucose monitoring and awareness of low blood sugar symptoms are emphasized in official warnings for this patient population.
Q: Does the time of year or temperature affect the use of Lantus?
Regulatory documents state that the rate of absorption and the time course of action for Lantus are dependent on many conditions, including local temperature. High external temperatures or fever can affect blood glucose levels and insulin requirements, making blood sugar monitoring particularly important in these situations.
